Fill-finish manufacturing is the process of aseptically filling biologics in any form such as solution, powder, or suspension in containers such as vials, syringes, cartridges, ampoules, bottles, and bags. It is an integral part of biopharmaceutical manufacturing after upstream-cell culture & downstream-separation and purification operations.

Key steps involved in the fill-finish process include cleaning, sterilization, filling, stoppering, lyophilization, capping, crimping, and visual inspection. The fill-finish manufacturing market is expected to reach USD 4.47 Billion by 2022 from USD 2.96 Billion in 2017, at a CAGR of 8.6%. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022.

Get More Details | Download the PDF Brochure@ http://bit.ly/2x8rk5S

The consumables segment is expected to hold the largest market share during the forecast period

On the basis of product, the fill-finish manufacturing market is segmented into consumables and instruments. In 2017, the consumables segment is expected to account for the largest share of the market. The dominant share of this segment can be attributed to the wide applications of vials in lyophilization, increasing demand for prefilled syringes, and the growth of the plastic prefilled syringes market.

The contract manufacturing organizations segment expected to grow at the highest rate in the next five years

On the basis of end user, the market is classified into contract manufacturing organizations, biopharmaceutical companies, and other end users. The contract manufacturing organizations segment is the fastest-growing segment in the fill-finish manufacturing market. This can primarily be attributed to the rising demand for outsourcing the fill-finish manufacturing process and growing number of new entrants in the biologics manufacturing market.

Europe is expected to dominate the fill-finish manufacturing market in 2017

In 2017, Europe is expected to account for the largest share of the global fill-finish manufacturing market. The large share of the European region is mainly attributed to factors such as the emergence of biosimilar market due to patent expiry of key biologic products, rising incidence of chronic disorders, and increasing focus of major players on enhancing their presence in Europe.

The APAC region is expected to grow at the highest CAGR over the next five years. The growth of the fill-finish manufacturing market in this region is fueled by the overall growth in the biopharmaceutical industry.

The key players operating in this market include Becton, Dickinson and Company (US), West Pharmaceutical Services, Inc. (West Pharmaceutical Services) (US), Gerresheimer AG (Gerresheimer) (Germany), Robert Bosch GmbH (Robert Bosch) (Germany), IMA (Italy), OPTIMA (Germany), and Nipro Medical Corporation (US).

Talk to Our Research Experts for More Detailed Information@ http://bit.ly/2x81aAQ